GEHCV
Income statement / Annual
Last year (2024), GE HealthCare Technologies Inc.'s total revenue was $19.67 B,
an increase of 0.61% from the previous year.
In 2024, GE HealthCare Technologies Inc.'s net income was $1.99 B.
See GE HealthCare Technologies Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$19.67 B |
$19.55 B |
$18.34 B |
$17.59 B |
$17.16 B |
$16.63 B |
| Cost of Revenue |
$11.47 B
|
$11.63 B
|
$11.16 B
|
$10.41 B
|
$10.40 B
|
$10.09 B
|
| Gross Profit |
$8.21 B
|
$7.92 B
|
$7.18 B
|
$7.17 B
|
$6.77 B
|
$6.55 B
|
| Gross Profit Ratio |
0.42
|
0.41
|
0.39
|
0.41
|
0.39
|
0.39
|
| Research and Development Expenses |
$1.31 B
|
$1.21 B
|
$1.03 B
|
$816.00 M
|
$810.00 M
|
$833.00 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.27 B
|
$4.28 B
|
$3.63 B
|
$3.56 B
|
$3.24 B
|
$3.59 B
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$5.58 B
|
$5.49 B
|
$4.66 B
|
$4.38 B
|
$4.05 B
|
$4.42 B
|
| Cost And Expenses |
$17.05 B
|
$17.12 B
|
$15.82 B
|
$14.79 B
|
$14.44 B
|
$14.51 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$34.00 M
|
$49.00 M
|
$36.00 M
|
| Interest Expense |
$504.00 M
|
$542.00 M
|
$77.00 M
|
$40.00 M
|
$66.00 M
|
$88.00 M
|
| Depreciation & Amortization |
$0.00
|
$610.00 M
|
$633.00 M
|
$625.00 M
|
$630.00 M
|
$659.00 M
|
| EBITDA |
$2.63 B |
$3.51 B |
$3.26 B |
$3.54 B |
$3.41 B |
$2.84 B |
| EBITDA Ratio |
0.13
|
0.18
|
0.18
|
0.2
|
0.2
|
0.17
|
| Operating Income Ratio |
0.13
|
0.12
|
0.14
|
0.16
|
0.16
|
0.13
|
| Total Other Income/Expenses Net |
-$44.00 M
|
-$74.00 M
|
-$44.00 M
|
-$12.00 M
|
$11.78 B
|
-$190.00 M
|
| Income Before Tax |
$2.58 B
|
$2.36 B
|
$2.51 B
|
$2.88 B
|
$14.50 B
|
$1.93 B
|
| Income Before Tax Ratio |
0.13
|
0.12
|
0.14
|
0.16
|
0.84
|
0.12
|
| Income Tax Expense |
-$531.00 M
|
-$743.00 M
|
$563.00 M
|
$600.00 M
|
$652.00 M
|
$410.00 M
|
| Net Income |
$1.99 B
|
$3.10 B
|
$1.95 B
|
$2.28 B
|
$13.85 B
|
$1.52 B
|
| Net Income Ratio |
0.1
|
0.16
|
0.11
|
0.13
|
0.81
|
0.09
|
| EPS |
4.37 |
6.82 |
4.29 |
0 |
0 |
0 |
| EPS Diluted |
4.34 |
6.78 |
4.29 |
0 |
0 |
0 |
| Weighted Average Shares Out |
$456.00 M
|
$455.00 M
|
$454.71 M
|
$0.00
|
$0.00
|
$0.00
|
| Weighted Average Shares Out Diluted |
$459.00 M
|
$458.00 M
|
$454.71 M
|
$0.00
|
$0.00
|
$0.00
|
| Link |
|
|
|
|
|
|
